Obstructive Sleep Apnea Medical Treatment including nPAP
description
Transcript of Obstructive Sleep Apnea Medical Treatment including nPAP
Obstructive Sleep ApneaMedical Treatment
including nPAP
A. Valipour, MD, FCCPDepartment of Respiratory and Critical Care
MedicineOtto-Wagner-HospitalVienna
• Prevalence: ~2-4% of population• Risk Factors:
• Obesity • Male Gender• Anatomic Risk Factors
• Symptoms: • Excessive Sleepiness• Snoring/Apneas/Choking• Cognitive Dysfunction/Depression
• Cardiovascular and metabolic morbidity and mortality
Obstructive Sleep Apnea: Fact Sheet
OSA: Medical Treatment
• Weight Loss• Positional Therapy• Drugs• Nasal dilators• nPAP• Alternatives?
Peppard PE, JAMA 2000
10% weight gain predicts 32% increase
in AHI
10% weight loss predicts 26% decrease
in AHI
Peppard PE, JAMA 2000
Berger G, Eur Respir J 2009
• 160 untreated Patients with Sleep Apnea • Age 50 ± 11yr• BMI 29 ± 5 kg/m2
• AHI 23 ± 22/hr
• Follow-Up Polysomnographic Recordings (5 ± 3 yrs)
Berger G, Eur Respir J 2009
Baseline vs. Follow-Up
15% Improvement
46% Stable
39% Deterioriation
Berger G, Eur Respir J 2009
Δ BMI 1kg/m2/yr↓
Δ AHI 5/hr
Positional therapy can yield moderate reductions in AHI but is clearly inferior to CPAP and long term compliance is poor.
Predictors of response: young age, lower AHI, less obese
Treatment: Positional Therapy
ERS Task Force „Non-CPAP therapies in Sleep Apnoea“, ERJ in press 2010
Antidepressants → suppression of REM sleep → increasing airway toneAcetazolamide → metabolic acidosis → resp. drive ↑Theophylline → respiratory drive ↑Doxapram → respiratory drive ↑
NO EVIDENCE THAT ANY DRUG IS LIKELY TO BENEFIT IN PATIENTS WITH OSA
Treatment: Drugs
ERS Task Force „Non-CPAP therapies in Sleep Apnoea“, ERJ in press 2010
Principle: Nasal dilation → Nasal resistance ↓→ fraction of oral ventilation ↓
Evidence: No consistent effect → snoring → apneas → sleep architecture
Treatment: Nasal Dilators
ERS Task Force „Non-CPAP therapies in Sleep Apnoea“, ERJ in press 2010
Treatment: Positive Airway Pressure Therapy
Pneumatic Splint of Upper Airway
Positive Airway Pressure Therapy:
Schwab RJ, AJRCCM 1996
CPAP↓
„Normalization“ of
upper airway dimensions
Positive Airway Pressure Therapy:
Schwab RJ, AJRCCM 1996
Indications for CPAP treatment
• AHI > 30/hr regardless of symptoms
• AHI 5-30/hr with symptoms, e.g.
• Excessive daytime sleepiness
• Insomnia
• Impaired cognition
• Cardiovascular disease
Loube DI, Chest 1999
Cassel W, Eur Respir J 1996
Becker HF, Circulation 2003
Dernaika TA, J Clin Sleep Med 2009
Drager LF, Am J Respir Crit Care Med 2007
Marin J et al., Lancet 2005
CPAP-Treatment: Reduction in cardiovascular morbidity and
mortality
CPAP use in a clinical setting
• Compliance/Adherence
• Side effects
• Humidification
• Auto-CPAP
• Expiratory pressure relief
Pépin JL et al, AJRCCM 1999
Kingshott RN, AJRCCM 2000
McArdle N et al, AJRCCM 1999
Regular use within first three months predicts long-term use
Sucena M, Eur Respir J 2006
Gay P, Sleep 2006
Up to 30% refuse or stop CPAP
therapy due to side effects
Mask problems
Nasal intolerance
Noise of the machine
Claustrophobia
CPAP: Side effects
Massie CA, Chest 1999
Potential strategies aimed at improving compliance and
decreasing side effects• Education and training
• Local therapy (Nose, Full Face Mask,…..)
• Humidification
• Auto-CPAP
• Expiratory Pressure Relief
Massie CA, CHEST 1999
Nussbaumer Y, Chest 2006
86% preferred Auto-CPAP over fixed CPAP
Ayas NT, SLEEP 2004;27:249-53.
CPAP vs. Auto-CPAP: no change in hours of use
Patruno V, Chest 2007
CPAP: Expiratory pressure relief
Nilius G, Chest 2006
No difference in compliance
after 7 weeks of treatment
EPR-PAP
Less side effects to the upper airways
↓ Need for humidification ↓
Potential benefit for Expiratory Pressure Relief PAP
Valipour A, ERS 2008
EPR-PAP
Pts. with symptomatic OSA requiring CPAP
Need for humidification?
CPAP
Need for humidification?
24 months 24 months
Matching: age, sex, BMI, OSA severity, sleepiness, CPAP pressure
Retrospective review of medical and insurance reports
3 sleep labs
Valipour A, ERS 2008
05
101520253035
CPAP EPR-PAP
% patients with humidifier prescription
p = 0.02
Valipour A, ERS 2008
37% reduction in humidifier prescription
with EPR-PAP
Alternatives to treat OSA with CPAP?
• High flow transnasal insufflation
(TNI)
• Expiratory nasal valves
• „Didgeridoo“
10L/min - 20L/minHigh Flow
Insufflation
„High Flow“ Transnasal Insufflation (TNI)
TNI creates positive pharyngeal pressure
McGinley BM, Am J Respir Crit Care Med 2007
McGinley BM, Am J Respir Crit Care Med 2007
Responders:
Upper Airway Resistance Syndrome
Sleep-Hypopnea-SyndromeMild OSAS
Nilius G, Chest 2009
Expiratory Nasal Valves
Nasal valve treatment:Expiratory resistance creates positive upper
airway pressure
Colrain IM, J Clin Sleep Med 2008
1. Weight reduction: first line
treatment
2. Drugs inefficient
3. Nasal dilators inefficient
Conclusions
1. CPAP: Gold standard treatment
2. Side-Effects:
Humidification: Auto-CPAP, EPR-PAP
3. TNI, Nasal Valves → mild OSA
Conclusions
Aim: Keep the upper airway open
Thank you for your attention
Positive airway pressure alternatives?
Puhan MA, British Medical Journal 2006
Puhan MA, British Medical Journal 2006
• Obesity (Visceral Fat)
• Male Gender
• Menopause
• Age
OSA: Clinical Risk Factors
Pathophysiology: mechanical upper airway obstructionPharygeal pressure < Atmospheric Pressure
Flow
SaO2
Thorax
Abdomen
Apnea Apnea
OSA: Polygraphic Recording
OSA: Pathophysiological Consequences
• Repetitive Hypoxia
• Intrathoracic Pressure Swings
• Sleep Fragmentation
• Hypersomnolence/Insomnia• Fatigue/Depression
• Traffic accidents/Work accidents
• Art. Hypertension• Arrythmias• Myocardial infarction, Stroke• Metabolic Consequences
OSA: Clinical Consequences
Nilius G, Chest 2006
Ayas NT, SLEEP 2004;27:249-53.
Auto-CPAP: Reduction in mean therapeutic pressure
Ayas NT, SLEEP 2004;27:249-53.
CPAP vs. Auto-CPAP: no difference in AHI
Patruno V, Chest 2007
Mador MJ, CHEST 2005
No significant difference in complianceNo significant difference in symptoms (ESS)
Solutions ?
Problems Noise and bulk Nasal intolerance
Mask related problems
Technologic improvement
Limitation of the leaks around the
mask
Nasal decongestants
Full Face Mask
Warm humidifier +++
Limitation of mouth leaks (mouth strap)
Good education
Adapted mask
Technologic improvement
Trained technician
Modified from Levy P, ERS Course 2005
Auto-CPAPEPR-PAP
Young T, AJRCCM 2002
Prevalence of OSA
Lee RWW, Sleep 2009
• Retrognathia
• Neck Size
• Tongue Size
• Uvula
• Tonsills
OSA: Anatomic Risk Factors
Diagnosis: Recording of Sleep and Breathing
New England J Medicine 1999
Goncalvez SC, Chest 2007
Parish JM, Chest 2009
Punjabi NM, PLOS Med 2009